scholarly journals Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”

Oncotarget ◽  
2017 ◽  
Vol 8 (19) ◽  
pp. 31368-31385 ◽  
Author(s):  
Anja Feldmann ◽  
Claudia Arndt ◽  
Ralf Bergmann ◽  
Simon Loff ◽  
Marc Cartellieri ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
T Lymphocytes ◽  
Cancer Cells ◽  
Chimeric Antigen Receptor ◽  
Antigen Receptor ◽  
The Novel ◽  
Prostate Cancer Cells ◽  
Platform Technology

scholarly journals The cytotoxic and pro-apoptotic activities of the novel fluoropyrimidine F10 towards prostate cancer cells are enhanced by Zn2+ -chelation and inhibiting the serine protease Omi/HtrA2

The Prostate ◽  
2014 ◽  
Vol 75 (4) ◽  
pp. 360-369 ◽  
Author(s):  
William H. Gmeiner ◽  
Olcay Boyacioglu ◽  
Christopher H. Stuart ◽  
Jamie Jennings-Gee ◽  
K.C. Balaji
Keyword(s):  
Prostate Cancer ◽  
Cancer Cells ◽  
Serine Protease ◽  
The Novel ◽  
Prostate Cancer Cells

scholarly journals Silencing the expression of Cbl-b enhances the immune activation of T lymphocytes against RM-1 prostate cancer cells in vitro

2014 ◽  
Vol 77 (12) ◽  
pp. 630-636 ◽  
Author(s):  
Shu-Kui Zhou ◽  
Wei-Hua Chen ◽  
Zheng-Duo Shi ◽  
Shun-Ping Wang ◽  
Liang Li ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
T Lymphocytes ◽  
Cancer Cells ◽  
Immune Activation ◽  
Prostate Cancer Cells

scholarly journals The Novel PIM1 Inhibitor NMS-P645 Reverses PIM1-Dependent Effects on TMPRSS2/ERG Positive Prostate Cancer Cells And Shows Anti-Proliferative Activity in Combination with PI3K Inhibition

2017 ◽  
Vol 8 (1) ◽  
pp. 140-145 ◽  
Author(s):  
Luca Mologni ◽  
Vera Magistroni ◽  
Francesco Casuscelli ◽  
Marisa Montemartini ◽  
Carlo Gambacorti-Passerini
Keyword(s):  
Prostate Cancer ◽  
Cancer Cells ◽  
Proliferative Activity ◽  
The Novel ◽  
Prostate Cancer Cells ◽  
Pi3k Inhibition
Sign in / Sign up

Export Citation Format

Share Document